NO20021379D0 - Benzodiazepin-derivater, fremstilling og anvendelse derav - Google Patents

Benzodiazepin-derivater, fremstilling og anvendelse derav

Info

Publication number: NO20021379D0
Authority: NO; Norway
Prior art keywords: preparation; benzodiazepine derivatives; benzodiazepine; derivatives
Prior art date: 1999-09-28

Application number

NO20021379A

Other languages

English (en)

Other versions

NO20021379L (no

Inventor

Wilfried Lubisch

Michael Kock

Thomas Hoeger

Roland Grandel

Reinhold Mueller

Sabine Schult

Original Assignee

Basf Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-28

Filing date

2002-03-20

Publication date

2002-03-20

2002-03-20 Application filed by Basf Ag filed Critical Basf Ag

2002-03-20 Publication of NO20021379L publication Critical patent/NO20021379L/no

2002-03-20 Publication of NO20021379D0 publication Critical patent/NO20021379D0/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Cardiology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Psychology (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Psychiatry (AREA)
Hematology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Surgery (AREA)
Emergency Medicine (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)

NO20021379A 1999-09-28 2002-03-20 Benzodiazepin-derivater, fremstilling og anvendelse derav NO20021379D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19946289A DE19946289A1 (de)	1999-09-28	1999-09-28	Benzodiazepin-Derivate, deren Herstellung und Anwendung
PCT/EP2000/009023 WO2001023386A2 (de)	1999-09-28	2000-09-15	Benzodiazepin-derivate, deren herstellung und anwendung

Publications (2)

Publication Number	Publication Date
NO20021379L NO20021379L (no)	2002-03-20
NO20021379D0 true NO20021379D0 (no)	2002-03-20

Family

ID=7923476

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20021379A NO20021379D0 (no)	1999-09-28	2002-03-20	Benzodiazepin-derivater, fremstilling og anvendelse derav

Country Status (21)

Country	Link
EP (1)	EP1222191B1 (no)
JP (1)	JP2003510324A (no)
KR (1)	KR20020031602A (no)
CN (1)	CN1376156A (no)
AR (1)	AR025721A1 (no)
AT (1)	ATE310003T1 (no)
AU (1)	AU7656700A (no)
BG (1)	BG106444A (no)
BR (1)	BR0014326A (no)
CA (1)	CA2384265A1 (no)
DE (2)	DE19946289A1 (no)
ES (1)	ES2251405T3 (no)
HK (1)	HK1048994A1 (no)
HU (1)	HUP0203225A3 (no)
IL (1)	IL148419A0 (no)
NO (1)	NO20021379D0 (no)
PL (1)	PL354118A1 (no)
SK (1)	SK3802002A3 (no)
TR (1)	TR200200820T2 (no)
WO (1)	WO2001023386A2 (no)
ZA (2)	ZA200104196B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100632079B1 (ko)	1999-01-11	2006-10-04	아구론 파마슈티컬스, 인크.	폴리(ａｄｐ-리보오스) 중합 효소의 트리사이클릭 저해제
WO2003103666A2 (en) *	2002-06-07	2003-12-18	Altana Pharma Ag	Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones
CA2493364A1 (en)	2002-07-26	2004-02-12	Basf Plant Science Gmbh	Inversion of the negative-selective effect of negative marker proteins using selection methods
WO2005028467A1 (en)	2003-09-15	2005-03-31	Anadys Pharmaceuticals, Inc.	Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds
US7772271B2 (en)	2004-07-14	2010-08-10	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
US7781478B2 (en)	2004-07-14	2010-08-24	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
US7868037B2 (en)	2004-07-14	2011-01-11	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
CA2578636A1 (en)	2004-07-22	2006-02-23	Ptc Therapeutics, Inc.	Thienopyridines for treating hepatitis c
CN102925479A (zh)	2005-03-08	2013-02-13	巴斯福植物科学有限公司	增强表达的内含子序列
US7662824B2 (en)	2005-03-18	2010-02-16	Janssen Pharmaceutica Nv	Acylhydrazones as kinase modulators
CA2782014C (en)	2009-11-27	2021-08-31	Basf Plant Science Company Gmbh	Optimized endonucleases and uses thereof
EP2504429B1 (en)	2009-11-27	2016-04-20	BASF Plant Science Company GmbH	Chimeric endonucleases and uses thereof
WO2011064751A1 (en)	2009-11-27	2011-06-03	Basf Plant Science Company Gmbh	Chimeric endonucleases and uses thereof
WO2012088266A2 (en)	2010-12-22	2012-06-28	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
SI2861595T1 (sl)	2012-06-13	2017-04-26	Incyte Holdings Corporation	Substituirane triciklične spojine kot inhibitorji fgfr
US9388185B2 (en)	2012-08-10	2016-07-12	Incyte Holdings Corporation	Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
JP2015533783A (ja) *	2012-09-05	2015-11-26	バイエル・クロップサイエンス・アクチェンゲゼルシャフト	非生物的な植物ストレスに対する活性物質としてのベンゾジアゼピノン類及びベンゾアゼピノン類又はそれらの塩の使用
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
ES2657451T3 (es)	2013-04-19	2018-03-05	Incyte Holdings Corporation	Heterocíclicos bicíclicos como inhibidores del FGFR
EP3144311A4 (en)	2014-05-16	2018-01-03	Shionogi & Co., Ltd.	Tricyclic heterocyclic derivative having hiv replication-inhibiting effect
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr)	2015-02-20	2017-12-26	Incyte Corp	Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
WO2016134294A1 (en)	2015-02-20	2016-08-25	Incyte Corporation	Bicyclic heterocycles as fgfr4 inhibitors
CA2976790C (en)	2015-02-20	2024-02-27	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
JP6614585B2 (ja) *	2015-05-29	2019-12-04	塩野義製薬株式会社	Ｈｉｖ複製阻害作用を有する含窒素３環性誘導体
CN105153195B (zh) *	2015-09-01	2017-09-26	汤文建	一种三环吡唑[1,5‑d][1,4]苯并氧氮杂卓酮衍生物及其制备方法与用途
AR111960A1 (es)	2017-05-26	2019-09-04	Incyte Corp	Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
KR20210018265A (ko)	2018-05-04	2021-02-17	인사이트 코포레이션	Fgfr 억제제의 고체 형태 및 이의 제조 방법
MX2020011639A (es)	2018-05-04	2021-02-15	Incyte Corp	Sales de un inhibidor de receptores de factor de crecimiento de fibroblastos (fgfr).
EP3886854A4 (en)	2018-11-30	2022-07-06	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof
WO2020185532A1 (en)	2019-03-08	2020-09-17	Incyte Corporation	Methods of treating cancer with an fgfr inhibitor
US11591329B2 (en)	2019-07-09	2023-02-28	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
WO2021067374A1 (en)	2019-10-01	2021-04-08	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
JP7675711B2 (ja)	2019-10-14	2025-05-13	インサイト・コーポレイション	Ｆｇｆｒ阻害剤としての二環式複素環
WO2021076728A1 (en)	2019-10-16	2021-04-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
CR20220285A (es)	2019-12-04	2022-10-27	Incyte Corp	Derivados de un inhibidor de fgfr
WO2021113479A1 (en)	2019-12-04	2021-06-10	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
WO2021146424A1 (en)	2020-01-15	2021-07-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
JP2024513575A (ja)	2021-04-12	2024-03-26	インサイト・コーポレイション	Ｆｇｆｒ阻害剤及びネクチン－４標的化剤を含む併用療法
EP4352060A1 (en)	2021-06-09	2024-04-17	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
AR126102A1 (es)	2021-06-09	2023-09-13	Incyte Corp	Heterociclos tricíclicos como inhibidores de fgfr

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL93136A (en) *	1989-02-23	1995-01-24	Janssen Pharmaceutica Nv	Tetrahydroimidazo (1,4) benzodiazepin-2-thione derivatives, their preparation and pharmaceutical compositions containing them
AU714873B2 (en) *	1995-08-02	2000-01-13	Newcastle University Ventures Limited	Benzimidazole compounds
ECSP003637A (es) *	1999-08-31	2002-03-25	Agouron Pharma	Inhibidores triciclicos de poli (adp-ribosa) polimerasas

1999
- 1999-09-28 DE DE19946289A patent/DE19946289A1/de not_active Withdrawn
2000
- 2000-09-15 DE DE50011656T patent/DE50011656D1/de not_active Expired - Lifetime
- 2000-09-15 IL IL14841900A patent/IL148419A0/xx unknown
- 2000-09-15 KR KR1020027003975A patent/KR20020031602A/ko not_active Ceased
- 2000-09-15 PL PL00354118A patent/PL354118A1/xx not_active Application Discontinuation
- 2000-09-15 HK HK03101161.8A patent/HK1048994A1/zh unknown
- 2000-09-15 SK SK380-2002A patent/SK3802002A3/sk unknown
- 2000-09-15 BR BR0014326-0A patent/BR0014326A/pt not_active IP Right Cessation
- 2000-09-15 WO PCT/EP2000/009023 patent/WO2001023386A2/de not_active Ceased
- 2000-09-15 AT AT00966022T patent/ATE310003T1/de not_active IP Right Cessation
- 2000-09-15 AU AU76567/00A patent/AU7656700A/en not_active Abandoned
- 2000-09-15 CA CA002384265A patent/CA2384265A1/en not_active Abandoned
- 2000-09-15 CN CN00813443A patent/CN1376156A/zh active Pending
- 2000-09-15 TR TR2002/00820T patent/TR200200820T2/xx unknown
- 2000-09-15 ES ES00966022T patent/ES2251405T3/es not_active Expired - Lifetime
- 2000-09-15 HU HU0203225A patent/HUP0203225A3/hu unknown
- 2000-09-15 JP JP2001526538A patent/JP2003510324A/ja not_active Ceased
- 2000-09-15 EP EP00966022A patent/EP1222191B1/de not_active Expired - Lifetime
- 2000-09-20 AR ARP000104924A patent/AR025721A1/es unknown
2001
- 2001-05-23 ZA ZA200104196A patent/ZA200104196B/xx unknown
2002
- 2002-02-22 ZA ZA200201494A patent/ZA200201494B/xx unknown
- 2002-02-26 BG BG06444A patent/BG106444A/xx unknown
- 2002-03-20 NO NO20021379A patent/NO20021379D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE50011656D1 (de)	2005-12-22
WO2001023386A2 (de)	2001-04-05
EP1222191B1 (de)	2005-11-16
AU7656700A (en)	2001-04-30
HUP0203225A3 (en)	2003-05-28
SK3802002A3 (en)	2003-03-04
EP1222191A2 (de)	2002-07-17
ZA200104196B (en)	2002-07-25
HUP0203225A2 (hu)	2003-01-28
CN1376156A (zh)	2002-10-23
WO2001023386A3 (de)	2002-05-10
BG106444A (en)	2002-09-30
PL354118A1 (en)	2003-12-29
CA2384265A1 (en)	2001-04-05
ZA200201494B (en)	2003-12-31
ES2251405T3 (es)	2006-05-01
IL148419A0 (en)	2002-09-12
JP2003510324A (ja)	2003-03-18
ATE310003T1 (de)	2005-12-15
NO20021379L (no)	2002-03-20
AR025721A1 (es)	2002-12-11
DE19946289A1 (de)	2001-03-29
HK1048994A1 (zh)	2003-04-25
TR200200820T2 (tr)	2002-09-23
BR0014326A (pt)	2002-05-28
KR20020031602A (ko)	2002-05-02

Publication	Publication Date	Title
NO20021379D0 (no)	2002-03-20	Benzodiazepin-derivater, fremstilling og anvendelse derav
NO20012567D0 (no)	2001-05-25	Azepinoindolderivater, fremstilling og anvendelse derav
NO20021449D0 (no)	2002-03-22	Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
IS6385A (is)	2002-05-15	Ný notkun og nýjar N-asabísýkló-amíð afleiður
NO20015156L (no)	2001-12-18	5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
DK1163244T3 (da)	2004-07-12	Thienopyrimidinforbindelser, fremstilling og anvendelse heraf
HUP0105414A3 (en)	2003-04-28	Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
IS6661A (is)	2002-12-19	Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun
IS2076B (is)	2006-02-15	Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
AU2002359126A8 (en)	2003-06-30	Benzodiazepine derivatives, preparation thereof and use thereof
DE60032898D1 (de)	2007-02-22	Arylthiazolidindion- und aryloxazolidinderivate
EE200100470A (et)	2002-12-16	Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
AU2002359123A8 (en)	2003-06-30	Benzodiazepine derivatives, preparation thereof and use thereof
IS6420A (is)	2002-06-13	Setnar Fenýl-píperazín afleiður, framleiðsla þeirra og notkun
TR200002099A3 (tr)	2001-06-21	Siklobüten türevleri, bunlarin hazirlanmasi ve terapötik kullanimlari
DK1043307T3 (da)	2003-09-22	3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1334106T3 (da)	2006-09-18	Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
NO20020156D0 (no)	2002-01-11	Titanavledede forbindelser, fremstilling og anvendelse derav
DK1025100T3 (da)	2002-05-06	3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf
NO20000066D0 (no)	2000-01-06	6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
NO20001782D0 (no)	2000-04-06	3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DE60005282D1 (de)	2003-10-23	Golfschlägerkopf, golfschläger und golfschlägerset
IS6391A (is)	2002-05-21	2-Arýlkínólín afleiður, framleiðsla og meðferðarleg notkun á þeim
DK1127052T3 (da)	2005-04-18	Substituerede 2-phenylbenzimidazoler, fremstilling og anvendelse heraf
NO981089D0 (no)	1998-03-12	Epoksy-azetidinoner, fremstilling og anvendelse derav

Legal Events

Date	Code	Title	Description
2003-06-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application